Multiple Ascending Dose Study of BMS-907351 (XL184) in Patients With Solid Tumors in Japan

NCT01018745 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
3
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Bristol-Myers Squibb